Skip to main content
. 2015 Aug 10;106(10):1463–1473. doi: 10.1111/cas.12741

Table 2.

Immunohistochemical analysis of ERGIC3 in various tumor tissues by using mAb 6-C4

Cancer ERGIC3 staining
Non-small cell lung cancer (NSCLC) 21/22
Pancreatic carcinoma 4/4
Hepatocellular carcinoma (HCC) 4/4
Gastric carcinoma 4/4
Esophagus carcinoma 10/10
Colorectal carcinoma 5/5
Renal cell carcinoma 9/9
Bladder carcinoma 11/12
Mammary carcinoma 5/6
Cervical carcinoma 9/10
Prostate cancer 9/11
Thyroid carcinoma 5/5
Osteosarcoma 0/3
Chondrosarcoma 0/2
Fibrosarcoma 0/3